PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

EndoChoice, Inc.

USPTO PatentsView assignee record — 123 granted patents across 17 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
123
Total patents granted
17
CPC technology areas
16.5
Avg claims per patent
+41%
5-year filing velocity

The verdict

EndoChoice holds 123 US patents across 17 technology areas — rank #3,077 of 50,000 tracked assignees.

#3,077
of 50,000 US assignees by volume
Top 21%
by Innovation Score (46.2/100)
16.5
avg claims per patent
+41%
filing velocity, last 5 yrs

Portfolio overview

EndoChoice, Inc. has been granted 123 US utility patents between 2015 and 2025, placing EndoChoice, Inc. at rank #3,077 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, EndoChoice, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 46.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 72 grants, compared with 51 in the 2015–2019 window — a +41% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. EndoChoice, Inc.'s 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark EndoChoice, Inc. against peers pursuing similar technology classes.

How does EndoChoice compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows EndoChoice holds 123 patents — placing it at rank #3,077 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

EndoChoice's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

05101520 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
EndoChoice, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 2.4%
2016 5 4.1%
2017 13 10.6%
2018 15 12.2%
2019 15 12.2%
2020 13 10.6%
2021 14 11.4%
2022 13 10.6%
2023 8 6.5%
2024 11 8.9%
2025 13 10.6%

Which technologies does EndoChoice, Inc. patent most?

Top 15 of 17 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#3,077

Across all tracked assignees

Innovation Score

46.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does EndoChoice, Inc. hold?
EndoChoice, Inc. holds 123 US granted patents filed between 2015 and 2025, spanning 17 technology areas.
What is EndoChoice, Inc.'s Innovation Score?
EndoChoice, Inc. has an Innovation Score of 46.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does EndoChoice, Inc. focus on?
EndoChoice, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 121 patents. The company has filed patents in 17 CPC subclasses total.
Is EndoChoice, Inc.'s patent filing rate increasing or decreasing?
EndoChoice, Inc.'s recent filing velocity is +41% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for EndoChoice, Inc.'s patents?
EndoChoice, Inc.'s patents average 16.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the EndoChoice, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61B technology

EndoChoice, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where EndoChoice, Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope